Clinical Trial Update: Pyridoxine in Preventing Hand-Foot Syndrome in Patients Who Are Receiving Capecitabine for Advanced Colorectal Cancer or Breast Cancer [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial is evaluating whether pyridoxine can prevent hand-foot syndrome in patients with advanced breast or colorectal cancer treated with cape…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Colorectal Cancer
• Hand-foot Syndrome

Drugs mentioned

• Capecitabine (capecitabine)
• Pyridoxine (Pyridoxine)

Snippet

Sponsor: Cambridge University Hospitals NHS Foundation Trust | Conditions: Breast Cancer, Colorectal Cancer | Phase 3 | Status: UNKNOWN